Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies.

Front Pharmacol · 2023 · PMC10374288 · PMID 37521468

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The level of VEGF expression may be significant in independently predicting the OS of melanoma patients ( Ugurel et al., 2001 ).

also in 7,049 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.